| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACTB
|
actin, beta
|
|
ADCY6
|
adenylate cyclase 6
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADRA1A
|
adrenoceptor alpha 1A
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
ANGPT2
|
angiopoietin 2
|
|
AP2B1
|
adaptor-related protein complex 2, beta 1 subunit
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
ARAP3
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3
|
|
ARG1
|
arginase 1
|
|
ARG2
|
arginase 2
|
|
ARRB1
|
arrestin, beta 1
|
|
ARRB2
|
arrestin, beta 2
|
|
ATF2
|
activating transcription factor 2
|
|
ATP1A1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide
|
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide
|
|
ATP1B2
|
ATPase, Na+/K+ transporting, beta 2 polypeptide
|
|
B2M
|
beta-2-microglobulin
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
C3
|
complement component 3
|
|
CACNB1
|
calcium channel, voltage-dependent, beta 1 subunit
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CD209
|
CD209 molecule
|
|
CD4
|
CD4 molecule
|
|
CDC42
|
cell division cycle 42
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal)
|
|
CHRNB2
|
cholinergic receptor, nicotinic, beta 2 (neuronal)
|
|
CTGF
|
connective tissue growth factor
|
|
CTSG
|
cathepsin G
|
|
CTSK
|
cathepsin K
|
|
CTSZ
|
cathepsin Z
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYTH1
|
cytohesin 1
|
|
CYTIP
|
cytohesin 1 interacting protein
|
|
DCN
|
decorin
|
|
DEFA1
|
defensin, alpha 1
|
|
DEFB1
|
defensin, beta 1
|
|
DEFB4A
|
defensin, beta 4A
|
|
EGFR
|
epidermal growth factor receptor
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
F2
|
coagulation factor II (thrombin)
|
|
FAS
|
Fas cell surface death receptor
|
|
FBLIM1
|
filamin binding LIM protein 1
|
|
FERMT3
|
fermitin family member 3
|
|
FOXC1
|
forkhead box C1
|
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1
|
|
GABRB2
|
gamma-aminobutyric acid (GABA) A receptor, beta 2
|
|
GABRE
|
gamma-aminobutyric acid (GABA) A receptor, epsilon
|
|
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GNAS
|
GNAS complex locus
|
|
GNB2
|
guanine nucleotide binding protein (G protein), beta polypeptide 2
|
|
GRK6
|
G protein-coupled receptor kinase 6
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GUCY1B2
|
guanylate cyclase 1, soluble, beta 2 (pseudogene)
|
|
HACE1
|
HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1
|
|
HDAC3
|
histone deacetylase 3
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIC1
|
hypermethylated in cancer 1
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB3
|
major histocompatibility complex, class II, DR beta 3
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICAM3
|
intercellular adhesion molecule 3
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IPO5
|
importin 5
|
|
ISL1
|
ISL LIM homeobox 1
|
|
ITGA9
|
integrin, alpha 9
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
KCNAB2
|
potassium channel, voltage gated subfamily A regulatory beta subunit 2
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KCNMB1
|
potassium channel subfamily M regulatory beta subunit 1
|
|
KCNMB2
|
potassium channel subfamily M regulatory beta subunit 2
|
|
LAMA3
|
laminin, alpha 3
|
|
LAMA4
|
laminin, alpha 4
|
|
LAMB1
|
laminin, beta 1
|
|
LAMB2
|
laminin, beta 2 (laminin S)
|
|
LAMC3
|
laminin, gamma 3
|
|
LBX1
|
ladybird homeobox 1
|
|
LDLRAP1
|
low density lipoprotein receptor adaptor protein 1
|
|
LTA
|
lymphotoxin alpha
|
|
LTB
|
lymphotoxin beta (TNF superfamily, member 3)
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAFA
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog A
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MPO
|
myeloperoxidase
|
|
MYLK
|
myosin light chain kinase
|
|
NEU1
|
sialidase 1 (lysosomal sialidase)
|
|
NEUROD1
|
neuronal differentiation 1
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
OPRM1
|
opioid receptor, mu 1
|
|
PDCD1
|
programmed cell death 1
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PLCB2
|
phospholipase C, beta 2
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKAB2
|
protein kinase, AMP-activated, beta 2 non-catalytic subunit
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
|
PRKAG1
|
protein kinase, AMP-activated, gamma 1 non-catalytic subunit
|
|
PRKAG2
|
protein kinase, AMP-activated, gamma 2 non-catalytic subunit
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRTN3
|
proteinase 3
|
|
PSMB2
|
proteasome (prosome, macropain) subunit, beta type, 2
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PURA
|
purine-rich element binding protein A
|
|
PXN
|
paxillin
|
|
RAB11A
|
RAB11A, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RAP2A
|
RAP2A, member of RAS oncogene family
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
|
RARB
|
retinoic acid receptor, beta
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
RP2
|
retinitis pigmentosa 2 (X-linked recessive)
|
|
RPL7
|
ribosomal protein L7
|
|
RS1
|
retinoschisin 1
|
|
S100A9
|
S100 calcium binding protein A9
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCN2A
|
sodium channel, voltage gated, type II alpha subunit
|
|
SCN2B
|
sodium channel, voltage gated, type II beta subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SELPLG
|
selectin P ligand
|
|
SIRPA
|
signal-regulatory protein alpha
|
|
SNAI1
|
snail family zinc finger 1
|
|
SYK
|
spleen tyrosine kinase
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
THRA
|
thyroid hormone receptor, alpha
|
|
TLN1
|
talin 1
|
|
TLR4
|
toll-like receptor 4
|
|
TNPO1
|
transportin 1
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VMA21
|
VMA21 vacuolar H+-ATPase homolog (S. cerevisiae)
|
|
VNN2
|
vanin 2
|
|
VWF
|
von Willebrand factor
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
YWHAQ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
